pyrrolo(1,2-a)quinoxaline has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alajarín, R; de Pascual-Teresa, B; Di Geronimo, B; García-Marín, J; Griera, M; Mendicuti, F; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Sánchez-Alonso, P; Vaquero, JJ | 1 |
1 other study(ies) available for pyrrolo(1,2-a)quinoxaline and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Pyrrolo[1,2-a]quinoxalines: Insulin Mimetics that Exhibit Potent and Selective Inhibition against Protein Tyrosine Phosphatase 1B.
Topics: Animals; Cell Differentiation; Cell Line; Cell Survival; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucose; Hep G2 Cells; Humans; Insulin; Mice; Models, Molecular; Molecular Structure; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyrroles; Quinoxalines; Structure-Activity Relationship | 2020 |